| Cytochrom P450-2C19 monooxygenase |
(R)-BICALUTAMIDE |
CYP450-2C19 Inhibition |
78% |
1uM |
NoneNone |
View
|
| dopamine receptor D1A |
CIGLITAZONE |
Dopamine D1 |
78% |
19.785uM |
9.893uM |
View
|
| cholinergic receptor, muscarinic 2 |
DEXCHLORPHENIRAMINE |
Muscarinic M2 |
78% |
6.994uM |
2.487uM |
View
|
| acetylcholinesterase (YT blood group) |
CIGLITAZONE |
Acetylcholinesterase |
78% |
15.026uM |
NoneNone |
View
|
| collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
CIGLITAZONE |
Acetylcholinesterase |
78% |
15.026uM |
NoneNone |
View
|
| acetylcholinesterase |
CIGLITAZONE |
Acetylcholinesterase |
78% |
15.026uM |
NoneNone |
View
|
| adenosine A2a receptor |
DIETHYLSTILBESTROL |
Adenosine A2A |
78% |
9.013uM |
5.06uM |
View
|
| tachykinin receptor 2 |
4-OCTYLPHENOL |
Tachykinin NK2 |
78% |
17.43uM |
5.81uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
PHENOTHIAZINE |
Serotonin 5-HT2C |
78% |
2.236uM |
1.171uM |
View
|
| dopamine receptor 2 |
AMITRIPTYLINE |
Dopamine D2L |
78% |
1.009uM |
.336uM |
View
|
| cholinergic receptor, muscarinic 1 |
AMOXAPINE |
Muscarinic M1 |
78% |
1.192uM |
.287uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
CHLOROXYLENOL |
Serotonin 5-HT2B |
78% |
1.856uM |
1.181uM |
View
|
| dopamine receptor D4 |
AMIODARONE |
Dopamine D4.2 |
78% |
17.72uM |
6.213uM |
View
|
| aldo-keto reductase family 1, member B4 (aldose reductase) |
ETHACRYNIC ACID |
Aldose Reductase |
78% |
1.15uM |
NoneNone |
View
|
| aldo-keto reductase family 1, member B1 (aldose reductase) |
ETHACRYNIC ACID |
Aldose Reductase |
78% |
1.15uM |
NoneNone |
View
|
| aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
ETHACRYNIC ACID |
Aldose Reductase |
78% |
1.15uM |
NoneNone |
View
|
| aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
ETHACRYNIC ACID |
Aldose Reductase |
78% |
1.15uM |
NoneNone |
View
|
| arachidonate 15-lipoxygenase, second type |
NIFEDIPINE |
Lipoxygenase 15-LO |
78% |
15.101uM |
NoneNone |
View
|
| arachidonate 15-lipoxygenase |
NIFEDIPINE |
Lipoxygenase 15-LO |
78% |
15.101uM |
NoneNone |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
ATROPINE |
Adrenergic alpha1D |
78% |
1.354uM |
.666uM |
View
|
| adrenergic receptor, alpha 2b |
CINNARIZINE |
Adrenergic alpha2B |
78% |
2.242uM |
1.023uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
| phosphodiesterase 5A, cGMP-specific |
TANNIC ACID |
Phosphodiesterase PDE5 |
77% |
4.703uM |
NoneNone |
View
|
| phosphodiesterase 5A, cGMP-specific |
TANNIC ACID |
Phosphodiesterase PDE5 |
77% |
4.703uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| adrenergic receptor, alpha 2a |
CARVEDILOL |
Imidazoline I2, Central |
76% |
1.92uM |
1.28uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
AMOXAPINE |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.507uM |
3.409uM |
View
|
| nuclear receptor subfamily 3, group C, member 1 |
CLOTRIMAZOLE |
Glucocorticoid |
77% |
3.258uM |
1.481uM |
View
|
| cholinergic receptor, muscarinic 3 |
AMIODARONE |
Muscarinic M3 |
77% |
3.201uM |
.679uM |
View
|
| histamine receptor H 2 |
CIMETIDINE |
Histamine H2 |
77% |
5.523uM |
5.431uM |
View
|
| histamine receptor H 2 |
TAMOXIFEN |
Histamine H2 |
77% |
9.396uM |
9.24uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
PROMAZINE |
Calcium Channel Type L, Benzothiazepine |
77% |
3.217uM |
2.86uM |
View
|
| carbonic anhydrase XII |
VALDECOXIB |
Carbonic Anhydrase |
75% |
4.574uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
PROMAZINE |
Calcium Channel Type L, Benzothiazepine |
77% |
3.217uM |
2.86uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
| epidermal growth factor receptor |
GOLD SODIUM THIOMALATE |
Protein Tyrosine Kinase, EGF Receptor |
76% |
2.379uM |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
BRIMONIDINE |
Serotonin 5-HT1A |
76% |
2.551uM |
1.458uM |
View
|
| opioid receptor, sigma 1 |
CLOMIPRAMINE |
Sigma1 |
76% |
1.362uM |
.572uM |
View
|
| histamine receptor H 2 |
CLOZAPINE |
Histamine H2 |
76% |
3.61uM |
3.55uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
TETRACAINE |
Serotonin 5-HT2C |
76% |
3.268uM |
1.712uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
CARVEDILOL |
Imidazoline I2, Central |
76% |
1.92uM |
1.28uM |
View
|
| Cytochrom P450-2D6 monooxygenase |
FLUOXETINE |
CYP450-2D6 Inhibition |
76% |
.7uM |
NoneNone |
View
|
| dopamine receptor D4 |
FLUPHENAZINE |
Dopamine D4.2 |
76% |
5.877uM |
2.061uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
HALOPERIDOL |
Adrenergic, Norepinephrine Transporter |
76% |
1.836uM |
1.82uM |
View
|
| dopamine receptor D1A |
BROMOCRIPTINE |
Dopamine D1 |
76% |
2.889uM |
1.444uM |
View
|
| adrenergic receptor, alpha 1a |
LYSERGOL |
Adrenergic alpha1A |
76% |
3.337uM |
1.351uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
METHYSERGIDE |
Calcium Channel Type L, Benzothiazepine |
76% |
3.559uM |
3.164uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
PAROXETINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.747uM |
.726uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
PAROXETINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.747uM |
.726uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
PAROXETINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.747uM |
.726uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
PAROXETINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.747uM |
.726uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
PAROXETINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.747uM |
.726uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
PAROXETINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.747uM |
.726uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
PAROXETINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.747uM |
.726uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
PAROXETINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.747uM |
.726uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
PAROXETINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.747uM |
.726uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
PAROXETINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.747uM |
.726uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
PAROXETINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.747uM |
.726uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
PAROXETINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.747uM |
.726uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
PAROXETINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.747uM |
.726uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
PAROXETINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.747uM |
.726uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
PAROXETINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.747uM |
.726uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
PAROXETINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.747uM |
.726uM |
View
|
| carbonic anhydrase XIV |
VALDECOXIB |
Carbonic Anhydrase |
75% |
4.574uM |
NoneNone |
View
|
| carbonic anhydrase VB, mitochondrial |
VALDECOXIB |
Carbonic Anhydrase |
75% |
4.574uM |
NoneNone |
View
|
| carbonic anhydrase VI |
VALDECOXIB |
Carbonic Anhydrase |
75% |
4.574uM |
NoneNone |
View
|
| carbonic anhydrase II |
VALDECOXIB |
Carbonic Anhydrase |
75% |
4.574uM |
NoneNone |
View
|
| carbonic anhydrase 5a, mitochondrial |
VALDECOXIB |
Carbonic Anhydrase |
75% |
4.574uM |
NoneNone |
View
|
| carbonic anhydrase 3 |
VALDECOXIB |
Carbonic Anhydrase |
75% |
4.574uM |
NoneNone |
View
|
| carbonic anhydrase 2 |
VALDECOXIB |
Carbonic Anhydrase |
75% |
4.574uM |
NoneNone |
View
|
| carbonic anhydrase 4 |
VALDECOXIB |
Carbonic Anhydrase |
75% |
4.574uM |
NoneNone |
View
|
| carbonic anhydrase XI |
VALDECOXIB |
Carbonic Anhydrase |
75% |
4.574uM |
NoneNone |
View
|
| carbonic anhydrase IX |
VALDECOXIB |
Carbonic Anhydrase |
75% |
4.574uM |
NoneNone |
View
|
| carbonic anhydrase VIII |
VALDECOXIB |
Carbonic Anhydrase |
75% |
4.574uM |
NoneNone |
View
|
| carbonic anhydrase VII |
VALDECOXIB |
Carbonic Anhydrase |
75% |
4.574uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
SIBUTRAMINE |
Calcium Channel Type L, Benzothiazepine |
75% |
.809uM |
.719uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
SIBUTRAMINE |
Calcium Channel Type L, Benzothiazepine |
75% |
.809uM |
.719uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
SIBUTRAMINE |
Calcium Channel Type L, Benzothiazepine |
75% |
.809uM |
.719uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
SIBUTRAMINE |
Calcium Channel Type L, Benzothiazepine |
75% |
.809uM |
.719uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
SIBUTRAMINE |
Calcium Channel Type L, Benzothiazepine |
75% |
.809uM |
.719uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
SIBUTRAMINE |
Calcium Channel Type L, Benzothiazepine |
75% |
.809uM |
.719uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
SIBUTRAMINE |
Calcium Channel Type L, Benzothiazepine |
75% |
.809uM |
.719uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
SIBUTRAMINE |
Calcium Channel Type L, Benzothiazepine |
75% |
.809uM |
.719uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
SIBUTRAMINE |
Calcium Channel Type L, Benzothiazepine |
75% |
.809uM |
.719uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
SIBUTRAMINE |
Calcium Channel Type L, Benzothiazepine |
75% |
.809uM |
.719uM |
View
|
| sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type IV, beta |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type IV, alpha |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type III, alpha |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type II, beta |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type II, alpha 2 |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type I, beta |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| adrenergic receptor, alpha 1b |
DOMPERIDONE |
Adrenergic alpha1B |
100% |
.158uM |
.087uM |
View
|
| sodium channel, voltage-gated, type I, alpha |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type IV, beta |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel associated protein 1 |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel associated protein 2 |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type III, beta |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type I, alpha |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type IX, alpha |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type VII, alpha |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| amiloride-sensitive cation channel 5, intestinal |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type III, beta |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type VIII, alpha polypeptide |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type XI, alpha |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type I, beta |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type 10, alpha polypeptide |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type IV, alpha polypeptide |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type V, alpha polypeptide |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type II, beta |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, nonvoltage-gated 1 gamma |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, nonvoltage-gated 1 beta |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, voltage-gated, type XI, alpha |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, nonvoltage-gated 1, gamma |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| sodium channel, nonvoltage-gated 1, delta |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| sodium channel, voltage-gated, type IV, alpha |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CLEMASTINE |
Calcium Channel Type L, Benzothiazepine |
78% |
2.241uM |
1.992uM |
View
|
| androgen receptor |
GENTIAN VIOLET |
Testosterone |
78% |
5.57uM |
3.713uM |
View
|
| thromboxane A synthase 1 |
GENISTEIN |
Thromboxane Synthetase |
78% |
7.72uM |
NoneNone |
View
|
| thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
GENISTEIN |
Thromboxane Synthetase |
78% |
7.72uM |
NoneNone |
View
|
| acetylcholinesterase (YT blood group) |
GENTIAN VIOLET |
Acetylcholinesterase |
78% |
5.847uM |
NoneNone |
View
|
| collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
GENTIAN VIOLET |
Acetylcholinesterase |
78% |
5.847uM |
NoneNone |
View
|
| acetylcholinesterase |
GENTIAN VIOLET |
Acetylcholinesterase |
78% |
5.847uM |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
| sodium channel associated protein 1 |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
| sodium channel associated protein 2 |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
| sodium channel, voltage-gated, type III, beta |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
| sodium channel, voltage-gated, type I, alpha |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|